Chimerix (CMRX) Reports In-Line Q1 EPS, Announces Strategy Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Chimerix Announces First Quarter 2019 Financial Results and Strategy Update
May 9, 2019 8:00 AM EDTReports Positive Top-line Survival Data from Pivotal Mouse Study as Key Milestone on Path to Smallpox Regulatory Submission
Plan to Focus on Execution of Smallpox Program, Halting All Other Brincidofovir Development Activities
Restructuring to Reduce Workforce by More Than 50%, Maintaining Key Capabilities and Preserving Capital for New Programs
Conference Call at 8:30 a.m. ET Today
DURHAM, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), today reported financial results for the first quarter ended March 31, 2019 and provided an update on... More



